Clear cell renal carcinoma - evolution of metastatic disease and overall survival after four lines of targeted therapy. Case report.Published in:Oncolog-Hematolog, 2017, n. 41, p. 32, doi. 10.26416/onhe.41.4.2017.1349By:Lăzescu, Andreea;Ciurea, Laura;Burlănescu, Ioan;Mitulescu, Dragoş;Grigorescu, AlexandruPublication type:Article
Immunotherapy and mTOR inhibitors a new perspective in the treatment of advanced and metastatic urothelial carcinomas.Published in:Oncolog-Hematolog, 2017, n. 39, p. 33By:Lăzescu, Andreea;Zob, Daniela;Stănculeanu, Dana;Ciurea, Laura;Zgură, Anca;Lupu, SimonaPublication type:Article